
Wosulin-N 40IU Suspension for Injection
Marketer
Wockhardt Ltd
Salt Composition
Insulin Isophane (40IU)
Overview Wosulin-N 40IU Suspension for Injection
InsuN-40, a 40IU injectable suspension, manages blood glucose in adults and children with type 1 and type 2 diabetes. This intermediate-acting insulin lowers blood sugar, mitigating the risk of diabetic complications. InsuN-40 is frequently used alongside rapid-acting insulin or oral hypoglycemics. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Discontinue only under medical supervision; it's a component of a comprehensive program including diet, exercise, and weight management as directed. Regular blood glucose monitoring and result reporting to your doctor are crucial for optimal dosage. Hypoglycemia (low blood sugar) is the most prevalent adverse effect. Accurate dosing, consistent meals, and vigilant blood sugar monitoring prevent this. Excessive alcohol consumption also increases hypoglycemia risk. Injection site reactions (redness, swelling) may occur; rotating injection sites avoids lipodystrophy (skin changes). Weight gain and edema (fluid retention) are potential side effects. Avoid InsuN-40 if hypoglycemic. Prior kidney, liver, or heart conditions require physician consultation before initiating treatment. Pregnant or breastfeeding individuals should discuss dosage adjustments with their doctor.
Primary Ingredients of Wosulin-N 40IU Suspension for Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Wosulin-N 40IU Suspension for Injection
High blood sugar condition
Major Benefits of Wosulin-N 40IU Suspension for Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it. Self-medication is strongly discouraged.
Common Side effects of Wosulin-N 40IU Suspension for Injection:
- Hypoglycemia (low blood glucose level)
How to use Wosulin-N 40IU Suspension for Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it. Self-medication is strongly discouraged.
How Wosulin-N 40IU Suspension for Injection works:
Nulin-40, a 40 IU injectable insulin suspension, offers intermediate-acting glucose control, beginning within one to two hours post-injection. Its mechanism mimics natural insulin function, promoting glucose uptake by muscle and adipose tissues while simultaneously inhibiting hepatic glucose production. This combined action effectively manages elevated blood glucose in patients with diabetes.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Wosulin-N 40IU Suspension for Injection is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Wosulin-N 40IU Injectable Suspension is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Wosulin-N 40 IU injectable suspension poses no known breastfeeding risks. Research in humans indicates minimal to negligible drug transfer via breast milk, presenting no apparent infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Wosulin-N 40IU injectable suspension cautiously. Dosage modification may be necessary; physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage adjustments.
LiverCAUTION
Patients with hepatic impairment should use Wosulin-N 40 IU injectable suspension cautiously, as dosage modification may be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage adjustments.
What if you forget to take Wosulin-N 40IU Suspension for Injection :
NA
Facts to Know About Wosulin-N 40IU Suspension for Injection
| Label | Value |
|---|---|
| Chemical Category | Analog insulin |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Intermediate-acting human insulin |
